Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:27 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 3,282,000 3.270% |
1,282,000 (+64.10%) |
Filing History |
| 2024-11-14 09:24 am Sale |
2024-09-30 | 13G | AnaptysBio, Inc. ANAB |
Deep Track Capital, LP | 0 0.000% |
-2,036,990 (Position Closed) |
Filing History |
| 2024-11-14 09:21 am Sale |
2024-09-30 | 13G | Agenus Inc. AGEN |
Deep Track Capital, LP | 0 0.000% |
-1,584,877 (Position Closed) |
Filing History |
| 2024-11-14 09:20 am Purchase |
2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Deep Track Capital, LP | 4,000,000 6.980% |
959,752 (+31.57%) |
Filing History |
| 2024-11-14 09:18 am Sale |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 15,922,655 8.650% |
-2,477,345 (-13.46%) |
Filing History |
| 2024-11-14 09:17 am Purchase |
2024-09-30 | 13G | Korro Bio, Inc. KRRO |
Deep Track Capital, LP | 850,000 9.140% |
135,715 (+19.00%) |
Filing History |
| 2024-11-14 09:16 am Purchase |
2024-09-30 | 13G | Invivyd, Inc. IVVD |
Deep Track Capital, LP | 10,953,937 9.170% |
1,953,937 (+21.71%) |
Filing History |
| 2024-11-14 09:13 am Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 4,096,452 7.880% |
1,812,080 (+79.33%) |
Filing History |
| 2024-11-14 09:12 am Purchase |
2024-09-30 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 15,272,172 5.740% |
3,402,875 (+28.67%) |
Filing History |
| 2024-11-14 09:09 am Sale |
2024-09-30 | 13G | ABIVAX SA ABVX |
Deep Track Capital, LP | 3,579,209 5.080% |
-718,229 (-16.71%) |
Filing History |
| 2024-10-24 4:06 pm Purchase |
2024-10-22 | 13D | Dynavax Technologies Corporation DVAX |
Deep Track Capital, LP | 17,791,486 13.600% |
5,265,000 (+42.03%) |
Filing History |
| 2024-10-23 4:15 pm Sale |
2024-10-22 | 13G | OnKure Therapeutics, Inc. OKUR |
Deep Track Capital, LP | 660,136 5.220% |
-24,020 (-3.51%) |
Filing History |
| 2024-10-11 4:00 pm Purchase |
2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR |
Deep Track Capital, LP | 684,156 5.410% |
684,156 (New Position) |
Filing History |
| 2024-10-07 4:17 pm Purchase |
2024-10-02 | 13G | Guardant Health, Inc. GH |
Deep Track Capital, LP | 6,580,257 5.350% |
579,697 (+9.66%) |
Filing History |
| 2024-10-07 4:00 pm Sale |
2024-09-30 | 13G | Guardant Health, Inc. GH |
Deep Track Capital, LP | 6,000,560 4.880% |
-999,440 (-14.28%) |
Filing History |
| 2024-09-23 4:00 pm Purchase |
2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX |
Deep Track Capital, LP | 3,018,935 9.480% |
3,018,935 (New Position) |
Filing History |
| 2024-09-16 4:05 pm Purchase |
2024-09-16 | 13D | Dynavax Technologies Corporation DVAX |
Deep Track Capital, LP | 12,526,486 9.560% |
5,433,272 (+76.60%) |
Filing History |
| 2024-07-12 4:04 pm Purchase |
2024-07-03 | 13G | Verona Pharma plc VRNA |
Deep Track Capital, LP | 32,932,392 5.080% |
32,932,392 (New Position) |
Filing History |
| 2024-07-02 4:01 pm Purchase |
2024-06-27 | 13G | Climb Bio, Inc. CLYM |
Deep Track Capital, LP | 3,904,785 5.850% |
3,904,785 (New Position) |
Filing History |
| 2024-05-10 4:00 pm Purchase |
2024-05-02 | 13G | Context Therapeutics Inc. CNTX |
Deep Track Capital, LP | 7,419,355 9.890% |
7,419,355 (New Position) |
Filing History |